Determinants of Early Recurrence of Cerebral Infarction, The Stroke Data Bank
Stroke 20:983-989, Sacco,R.L.,et al, 1989
Histological Verification of Microaneurysms as a Cause of Cerebral Haemorrhage in Surgical Specimens
JNNP 52:595-599, Wakai,S.&Nagai,M., 1989
Anterior Operculum Syndrome
Neurol 39:1169-1172, Mao,C.C.,et al, 1989
Cerebrovascular Disease & Antiphospholipis Antibodies in SLE, Lupus-Like Dis, & Primary Antiphospholipid Synd
Am J Med 86:391-399, Asherson,R.A.,et al, 1989
Interrater Reliability of the NIH Stroke Scale
Arch Neurol 46:660-662, Goldstein,L.B.,et al, 1989
Intraluminal Clot in the Vertebrobasilar Circulation:Clinical and Radiologic Features
Neurol 39:515-522, Levine,S.R., 1989
Stroke Associated with Cocaine Use
Arch Neurol 46:989-993, Klonoff,D.C.,et al, 1989
Relative Diagnostic Value of Cerebrospinal Fluid Kappa Chains in MS:Comparison with Other Immunoglobulin Tests
Neurol 39:964-968, Rudnick,R.A.,et al, 1989
Patterns of Neurologic Involvement in Multiple Sclerosis
Neurol 39:1235-1238, Kurtzke,J.F., 1989
Magnetic Resonance Imaging of Spinal Cord Lesions in Multiple Sclerosis
JNNP 52:459-466, Honig,L.S.&Sheremata,W.A., 1989
A Referendum on Clinical Trial Research in Multiple Sclerosis:Opinion of Jekyll Island Workshop
Neurol 39:977-981, Noseworthy,J.H.,et al, 1989
Isolation of Herpes Simplex Virus Type 1 During First Attack of Multiple Sclerosis
Ann Neurol 26:283-285, Bergstrom,T.,et al, 1989
Diagnosis of Multiple Sclerosis, Remains Essentially Clinical Though Silent Lesions Can Now be Identified
BMJ 299:635-637, McDonald,W.I., 1989
Amantadine Treatment of Fatigue Associated with Multiple Sclerosis
Arch Neurol 46:676-680, Cohen,R.A.&Fisher,M., 1989
Relative Efficacy of Intravenous Methylprednisolone and ACTH in the Treatment of Acute Relapse in MS
Neurol 39:969-971, Thompson,A.J.,et al, 1989
Sensory Tics in Tourette's Syndrome
Neurol 39:731-734, Kurlan,R.,et al, 1989
Double-Blind Study of True vs. Sham Plasma Exchange in Patients Treated with Immunosuppression for Acute Attacks of MS
Neurol 39:1143-1149, Weiner,H.L.,et al, 1989
Randomised Double Blind Controlled Trial of Cyclosporin in Multiple Sclerosis
JNNP 52:559-565, Rudge,P.,et al, 1989
A Placebo-Controlled, Randomized, Clinical Trial of Azathioprine with & without Methylpred in MS
Neurol 39:1018-1026, Ellison,G.W.,et al, 1989
Immunological Treatment for Multiple Sclerosis
Editorial, Lancet 1:699-7011989., , 1989
Treatment of Cerebellar Tremors with Carbamazepine:A Controlled Trial with Long-Term Follow-Up
Neurol 39:1113-1115, Sechi,G.P.,et al, 1989
Frequency, Etiology, and Prevention of Stroke in Patients with Systemic Lupus Erythematosus
Stroke 20:583-591, Futrell,N.&Millikan,C., 1989
Aseptic Meningitis Complicating Adult Kawasaki Disease:Case Report and Review of the Literature
Am J Med 87:106-110, McIlroy,M.A.,et al, 1989
An Epidemiologic Study of Headache Among Adolescents and Young Adults
JAMA 261:2211-2216, Linet,M.S.,et al, 1989
Tuberculous Meningitis in Children:Treatment with Isoniazid and Rifampicin for Twelve Months
J Pediatr 114:875-879, Visudhiphan,P.&Chiemchanya,S., 1989
Dural Scrofula
Neurol 39:1123-1124, Glass,J.D.,et al, 1989
Pseudallescheria Boydii Brain Abscess:With Near-Drowning & Miconazole Therapy with Multiple Abscesses
Medicine 66:218-224, Dworzack,D.L.,et al, 1989
Lyme Disease
NEJM 321:586-596, Steere,A.C., 1989
Central Nervous System Manifestations of Lyme Disease
Arch Neurol 46:790-795, Pachner,A.R.,et al, 1989
Lyme Neuroborreliosis:Central Nervous System Manifestations
Neurol 39:753-759, Halperin,J.J.,et al, 1989
Multiple Pyogenic Brain Abscesses:An Analysis of 21 Patients
JNNP 52:591-594, Basit,A.S.,et al, 1989
Brain Damage by Neonatal Hypoglycaemia
Editorial, Lancet 1:882-8831989., , 1989
Cranial Nerve Deficit:A Clue to the Diagnosis of Ethylene Glycol Poisoning
Am J Med 87:91-92, Palmer,B.F.,et al, 1989
Cerebrovascular Complications of Mucinous Cancers
Neurol 39:522-526, Amico,L.,et al, 1989
Neurologic Eye Signs Following Motorcycle Accidents
Arch Neurol 46:761-762, Keane,J.R., 1989
Intrathecal Baclofen for Severe Spinal Spasticity
NEJM 320:1517-1521, 1553-15551989., Penn,R.D.,et al, 1989
Intrathecal Baclofen for Long-Term Treatment of Spasticity:A Multi-Centre Study
JNNP 52:933-939, Ochs,G.,et al, 1989
Magnetism, A New Method for Stimulation of Nerve and Brain
JAMA 262:538-541, Hallett,M.&Cohen,L.G., 1989
Accuracy of Self-Reported Disability in Patients with Parkinsonism
Arch Neurol 46:955-959, Brown,R.G.,et al, 1989
Multiple Sclerosis Simulating Brain Tumor on Computed Tomography
J Comput Assist Tomogr 13:674-678, Otsuka,S.I.,et al, 1989
Cerebrospinal Fluid Immunoglogulins & MS, Correspondence MRI & Visually Evoked Potential Changes
Arch Neurol 46:367-371, Miller,F.A.J.,et al, 1989
The Lesion of Multiple Sclerosis:Imaging of Acute and Chronic Stages
Neurol 39:959-963, Koopmans,R.A.,et al, 1989
Chronic Progressive Multiple Sclerosis:Serial Magnetic Resonance Brain Imaging Over Six Months
Ann Neurol 26:248-256, Koopmans,R.A.,et al, 1989
Dissociative States and Epilepsy
Neurol 39:835-840, Devinsky,O.,et al, 1989
Transient Ocular Motor Paresis Associated with Acute Internal Carotid Artery Occlusion
Ann Neurol 25:286-290, Wilson,W.B.,et al, 1989
The Disability Status Scale for Multiple Sclerosis:Apologia Pro DSS Sau
Neurol 39:291-302, Kurtzke,J.F., 1989
Cognitive Loss in Multiple Sclerosis
Arch Neurol 46:162-167, Franklin,G.M.,et al, 1989
Correlation of Magnetic Resonance Imaging with Neuropsychological Testing in Multiple Sclerosis
Neurol 39:161-166, Rao,S.M.,et al, 1989
Consensus and Controversy in Neurologic Practice, The Case of Steroid Treatment in Multiple Sclerosis
Arch Neurol 46:322, Menken,M., 1989
Quantitative Magnetic Resonance Imaging in Multiple Sclerosis:The Effect of High Dose Intravenous Methylprednisolone
JNNP 52:14-17, Kesselring,J.,et al, 1989